Tumor immunity: a novel dimension for PROTACs to conquer cancer?

Chen, Xuan-Kun; Zhao, Wen-Bin; Zhou, Zhan; Cao, Ji

Chen, Xuan-Kun; Zhao, Wen-Bin; Zhou, Zhan; Cao, Ji.

Afiliação

Chen XK; Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Zhao WB; The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, 310058, China. pharmacy_zwb@zju.edu.cn.
Zhou Z; Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. zhanzhou@zju.edu.cn.
Cao J; The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, 310058, China. zhanzhou@zju.edu.cn.

Acta Pharmacol Sin ; 43(8): 2171-2172, 2022 08.

Article em En | MEDLINE | ID: mdl-34983932

Assuntos

Neoplasias; Humanos; Peptídeos e Proteínas de Sinalização Intercelular; Neoplasias/tratamento farmacológico; Neoplasias/patologia; Proteólise; Ubiquitina-Proteína Ligases/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Revista: Acta Pharmacol Sin Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google